Fruit fly gene study could yield new flu treatmentsJuly 10, 2008As they design new drugs to fight off influenza, scientists may not need to attack the virus directly. Instead, they may be able to stave off infection by targeting one of more than 100 proteins inside host cells on which the virus depends. These potential drug targets are the result of a study in which scientists, led by Howard Hughes Medical Institute investigator Paul Ahlquist and colleague Yoshihiro Kawaoka at the University of Wisconsin-Madison, tested the ability of a modified influenza virus to infect fruit fly cells. "Our findings give us considerable hope that-with a large number of host targets to choose from-we could develop drugs to more stably suppress the virus and not allow the virus to evolve nearly as quickly to generate resistance," Ahlquist said. The team described their findings in a July 9, 2008, advance online publication of the journal Nature. Viruses possess only a limited number of genes, so they must hijack a host cell's own protein machinery to enter the cell and replicate their genes. Relatively few of influenza's interactions with host proteins are understood, according to Ahlquist, and this has limited drug development.
"So far, antiviral treatments against influenza have targeted specific viral enzymes or functions," he said. "The problem has been that the virus can mutate itself to develop resistance to these drugs. Our hope is that by identifying host functions on which the influenza virus depends, we can develop drugs that target these functions. And since those functions are encoded by the host, the virus cannot use simple mutations to develop resistance to such drugs." Although fruit flies are not naturally infected by the influenza virus, Ahlquist and his colleagues knew the fly would be a powerful tool in identifying the genes and proteins that facilitate infection. A great many fly genes have counterparts in humans, and the researchers could analyze the function of individual fly genes using a technique known as RNA interference. So the researchers genetically altered influenza virus so that it could infect cultured fruit fly cells grown in the laboratory. They also added a gene that would produce a telltale fluorescence when the virus successfully replicated in fly cells. They next used RNA interference -- treating fly cells with small snippets of RNA -- to individually suppress the function of each of 13,071 genes, representing 90 percent of all fly genes. If a gene is important for allowing the virus to replicate, fly cells in which that gene had been shut off would not emit the fluorescent signal signifying infection. Using this screen, the researchers identified more than 100 host cell genes that the virus depended on for infection. "We found that the virus depends on the function of fly genes in a wide range of cellular processes," said Ahlquist. "This tells us that quite a variety of host functions are important to the virus and that there could be a broad range of options for antiviral drugs." The researchers wanted to be sure that their findings were relevant for influenza infections that occur outside of the laboratory. So, as an initial check, they tested the ability of natural strains of the virus to infect mammalian cells lacking three of the genes they had identified in the fruit fly cells. The genes they chose participate in three different cellular processes known to be involved in the life cycle of the virus. They found that suppressing the function of any of the three diverse genes-called ATP6V0D1, COX6A1 and NXF1-thwarted viral replication. The researchers also tested how blocking these genes might affect infection with other viruses, and found that all three genes were influenza-specific. Suppressing them did not affect replication of two other viruses they tested. Thus, said Ahlquist, the influenza virus functions in a way that is distinct from the other viruses and that may offer a prime target for influenza-specific antiviral drugs. Howard Hughes Medical Institute | |||||||||||||||||||||
|
Related Influenza Virus Current Events and Influenza Virus News Articles Flu shot does not reduce risk of death The widely-held perception that the influenza vaccination reduces overall mortality risk in the elderly does not withstand careful scrutiny, according to researchers in Alberta. Discovery opens door for drugs to fight bird flu, other influenza epidemics Researchers at Rutgers University and The University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight the much-feared bird flu and other virulent strains of influenza. Bacterial pneumonia caused most deaths in 1918 influenza pandemic The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Survivors of 1918 flu pandemic protected with a lifetime immunity to virus New research has discovered that infection and natural exposure to the 1918 influenza virus made survivors immune to the disease for the remaining of their lives. Mobilizing white blood cells to the lung: New discovery could lead to an improved influenza vaccine Findings just published in the scientific journal Immunity by researchers at the Trudeau Institute shed new light on how a previously-unknown messaging mechanism within the human immune system prompts specific influenza-fighting cells to the lung airways during an infection. Getting wise to the influenza virus' tricks Influenza is currently a grave concern for governments and health organisations around the world. The worry is the potential for highly virulent bird flu strains, such as H5N1, to develop the ability to infect humans easily. New drugs and vaccines to halt the spread of the virus are badly needed. New strategies against bird flu The Spanish flu outbreak of 1918 killed between 30 and 50 million people. In the infected patients, the ultimate cause of death was acute respiratory distress syndrome (ARDS). Study provides new understanding of forces behind seasonal flu virus evolution Do influenza viruses persist in low levels year-round in the northern and southern hemispheres, or does a new crop of the virus emerge afresh in tropical zones such as Southeast Asia before spreading into temperate regions around the globe" Researchers have provided an answer to this long-standing question: new strains arise each year. Scientists create first successful libraries of avian flu virus antibodies An international group of American and Turkish research scientists, led by Sea Lane Biotechnologies, has created the first comprehensive monoclonal antibody libraries against avian influenza (H5N1) using samples from survivors of the 2005/2006 "bird flu" outbreak in Turkey. Molecular evolution of influenza A viruses circulated in Fujian Province, China Fujian Center for Disease Control & Prevention, China, reported the molecular evolution of influenza A (H3N2) viruses in Fujian Province, south of China during the period 1996 - 2004 and demonstrated some key codons responsible for antigenic drift. The study is reported in Issue 51 (April, 2008) of the Science in China Series C: Life Science because of its significant impact. More Influenza Virus Current Events and Influenza Virus News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||